Ameritox, Ltd.

34 articles about Ameritox, Ltd.

• Ameritox, Ltd. Research Confirms Significant Spike In Potential Nonadherence To Opioid Medications

  2/22/2016

• Millennium Health To Pay $8.6 Million For Infringing On Ameritox, Ltd.-Licensed Patent

  4/22/2015

• Federal Court Rules Millennium Health Infringes Patent Exclusively Licensed To Ameritox, Ltd.

  3/12/2015

• Ameritox, Ltd. To Present Clinical Research To Forensic Toxicology Scientific Community

  10/23/2014

• Ameritox, Ltd. And Ingenuity Health Expand Effort To Help Assess Medication Adherence In Those With Serious Mental Illness

  10/21/2014

• Ameritox, Ltd. Appoints New Chief Medical Officer

  10/17/2014

• Ameritox, Ltd. And Ingenuity Health Building Comprehensive Reference Database To Help Assess Medication Adherence In Those With Serious Mental Illness

  8/14/2014

• Ameritox, Ltd. Sponsors Youth Basketball Camps Focused On Drug Abuse Prevention

  6/30/2014

• Ameritox, Ltd. Awarded $14.775 Million in Unfair Competition Case Against Millennium Laboratories

  6/17/2014

• Ameritox, Ltd. Lends Support to DEA Drug Take-Back Events

  10/9/2013

• Ameritox, Ltd. Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers

  5/24/2013

• Agilent Technologies Inc. and Ameritox, Ltd. Form Collaboration, Aim to Advance Analysis of Medication Monitoring

  2/11/2013

• Ameritox, Ltd. Leadership Supports Lawmakers, Pain Practitioners and Patients Confronting Crisis in Pain Medication Abuse

  1/31/2013

• Ameritox, Ltd. Joins Coalition for Excellence in Medication Monitoring

  1/9/2013

• Ameritox, Ltd. and Wake Forest University Form Research Partnership

  12/5/2012

• Ameritox, Ltd. Symposium to Help Educate Physicians About Emerging Trends in Opioid, Designer Drug Misuse and Abuse at Third Annual CASIPPMeeting

  11/9/2012

• Ameritox, Ltd. Launches Critical, New Synthetic Marijuana Drug Test to Help Physicians Detect Rising Use of Dangerous Designer Drugs

  10/3/2012

• Ameritox, Ltd.(SM) Offers Unique Monitoring Service to Support Physicians on Front Lines of Oxymorphone Misuse and Abuse

  9/19/2012

• Ameritox, Ltd. Release: New Analysis Shows Illicit Drug Use May Vary by Payer Type: Detection Rates as High as 17 Percent

  9/10/2012

• Ameritox, Ltd. Appoints New CEO, Scott Walton

  9/5/2012